PARIS-- (BUSINESS WIRE)--Okomera, a TechBio company pioneering personalized cancer care through a proprietary technology platform combining tumor mini-avatars, microfluidics, and AI-powered imaging, ...
A City Council committee voted unanimously Wednesday to stop using ALPRs. The matter could come before the full council soon.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results